Copyright
©The Author(s) 2019.
World J Hepatol. Jul 27, 2019; 11(7): 586-595
Published online Jul 27, 2019. doi: 10.4254/wjh.v11.i7.586
Published online Jul 27, 2019. doi: 10.4254/wjh.v11.i7.586
Table 1 Drugs and toxins implicated in cases of acute liver failure managed at the Victorian Liver Transplant Unit from 2002-2017
Drug/Toxins | Cases of ALF | Waitlisted for ELT | ELT |
(n = 101) | (n = 21) | (n = 13) | |
Paracetamol | 84 | 11 | 3 |
Antibiotics | 4 | 2 | 2 |
Amoxicillin/clavulanate (2), clarithromycin, isoniazid | |||
Infliximab | 2 | 2 | 2 |
Illicit drugs | 4 | 1 | 1 |
LSD, injected buprenorphine, amphetamines, MDMA | |||
NSAIDs | 1 | 1 | 1 |
Amanita phalloides | 1 | 1 | 1 |
Herbal medicines | |||
Black cohosh herb, kava kava | 2 | 2 | 2 |
Other | |||
Moxonidine, fenofibrate, chlorambucil | 3 | 1 | 1 |
- Citation: Hey P, Hanrahan TP, Sinclair M, Testro AG, Angus PW, Peterson A, Warrillow S, Bellomo R, Perini MV, Starkey G, Jones RM, Fink M, McClure T, Gow P. Epidemiology and outcomes of acute liver failure in Australia. World J Hepatol 2019; 11(7): 586-595
- URL: https://www.wjgnet.com/1948-5182/full/v11/i7/586.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i7.586